| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |